AQA
GILD icon

Alpha Quant Advisors’s Gilead Sciences GILD Stock Holding History

Alpha Quant Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.19M Sell
18,229
-625
-3% -$41.5K 1.19% 32
2018
Q4 		$1.18M Buy
+18,854
New +$1.32M 1.22% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alpha Quant Advisors's GILD Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Gilead Sciences (GILD) stake by 3.3% in Q1 2019, selling an estimated $41.5K and leaving 18,229 shares worth $1.19M. The position accounts for 1.19% of the portfolio, ranked #32.

Alpha Quant Advisors first reported a position in GILD in Q4 2018 and has held it in 2 quarters since. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Alpha Quant Advisors held 18,229 shares of Gilead Sciences worth $1.19M as of Q1 2019.
  • Alpha Quant Advisors sold 625 Gilead Sciences shares in Q1 2019, an estimated $41.5K.
  • Gilead Sciences made up 1.19% of Alpha Quant Advisors's portfolio in Q1 2019, its #32 holding.
  • Alpha Quant Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 2 quarters since.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.